| scholarly article | Q13442814 |
| P2093 | author name string | S. Zhang | |
| K. O. Lloyd | |||
| P. O. Livingston | |||
| A. K. Singhal | |||
| C. Cordon-Cardo | |||
| V. E. Reuter | |||
| H. S. Zhang | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures | Q26778382 | ||
| A spectrum of monoclonal antibodies reactive with human mammary tumor cells | Q35367479 | ||
| Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants | Q36014843 | ||
| Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas | Q37689348 | ||
| Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Lea and sialosyl-Lex, and sulfated glycans modulate this binding | Q38331669 | ||
| Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues | Q39753668 | ||
| Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides | Q48615588 | ||
| Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate Antigen | Q68145704 | ||
| Human monoclonal antibody to ganglioside GM2 for melanoma treatment | Q69368376 | ||
| Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma | Q70312618 | ||
| Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant | Q70577158 | ||
| Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer | Q71058121 | ||
| T and Tn, general carcinoma autoantigens | Q71372455 | ||
| Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside | Q72377535 | ||
| Monoclonal antibody against a cryptic carbohydrate antigen of murine and human lymphocytes. I. Antigen expression in non-cryptic or unsubstituted form on certain murine lymphomas, on a spontaneous murine mammary carcinoma, and on several human adeno | Q72722741 | ||
| P4510 | describes a project that uses | immunohistochemistry | Q899285 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 50-56 | |
| P577 | publication date | 1997-09-01 | |
| 1997-09-26 | |||
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens | |
| P478 | volume | 73 |
| Q36604334 | A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity. |
| Q36841027 | A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission |
| Q37303845 | A Vision for Vaccines Built from Fully Synthetic Tumor-Associated Antigens: From the Laboratory to the Clinic |
| Q37380026 | A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis |
| Q36442488 | A novel synthetic bipartite carrier protein for developing glycotope-based vaccines |
| Q34470586 | A practical total synthesis of globo-H for use in anticancer vaccines |
| Q34010347 | A strategy for the selective imaging of glycans using caged metabolic precursors |
| Q64986685 | AB0 Blood Group and Ovarian Cancer Survival. |
| Q61455231 | ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China |
| Q37131928 | ABO blood group and the risk of pancreatic cancer |
| Q64966406 | ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. |
| Q40053847 | ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study |
| Q57821545 | Aberrant O-glycosylation modulates aggressiveness in neuroblastoma |
| Q38754498 | Adoptive T-Cell Therapy for Solid Tumors |
| Q34244875 | Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice |
| Q35669639 | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. |
| Q37581540 | Altered tumor-cell glycosylation promotes metastasis |
| Q37606151 | Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China |
| Q33924634 | Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues |
| Q37186518 | Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains. |
| Q35525289 | Cancer vaccines and carbohydrate epitopes |
| Q59335766 | Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers |
| Q41629044 | Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale |
| Q40879087 | Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans |
| Q37426039 | Carbohydrate vaccines: developing sweet solutions to sticky situations? |
| Q36802325 | Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines |
| Q83899971 | Chemistry and glycobiology |
| Q41558781 | Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia |
| Q36386891 | Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies |
| Q83886953 | Clinical Application of Serum Tumor Associated Material (TAM) from Non-small Cell Lung Cancer Patients |
| Q84818635 | Comparison of Serum Tumor Associated Material (TAM) with Conventional Biomarkers in Cancer Patients |
| Q77526041 | Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines |
| Q40735450 | Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies |
| Q33853098 | Convergent syntheses of Le analogues |
| Q91776744 | Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia |
| Q90616352 | Facile chemoenzymatic synthesis of Lewis a (Lea) antigen in gram-scale and sialyl Lewis a (sLea) antigens containing diverse sialic acid forms |
| Q53703015 | Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy |
| Q63641065 | Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells |
| Q43143675 | Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. |
| Q38910650 | Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression. |
| Q36148438 | Glycans in cancer and inflammation--potential for therapeutics and diagnostics |
| Q33659849 | Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies |
| Q36109568 | Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications |
| Q48169265 | Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines. |
| Q39505101 | Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA. |
| Q51985601 | Immunization of Rhesus monkeys with the conjugate vaccine IGN402 induces an IgG immune response against carbohydrate and protein antigens, and cancer cells |
| Q46952255 | Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). |
| Q47936113 | Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. |
| Q38109954 | Influence of ABO blood group and Rhesus factor on breast cancer risk: A meta‐analysis of 9665 breast cancer patients and 244 768 controls |
| Q39305177 | Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line |
| Q34550700 | Integration of the Transcriptome and Glycome for Identification of Glycan Cell Signatures |
| Q44436753 | Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli |
| Q48566108 | Mannosylated T/Tn with Freund's adjuvant induces cellular immunity. |
| Q40399854 | Minimally invasive prostate cancer detection test using FISH probes |
| Q73229844 | Monoclonal antibody DS6 detects a tumor-associated sialoglycotope expressed on human serous ovarian carcinomas |
| Q37137385 | Natural and Induced Humoral Responses to MUC1. |
| Q35558057 | Novel and emerging targeted-based cancer therapy agents and methods |
| Q34160588 | On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. |
| Q37316845 | Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia |
| Q37105366 | Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database |
| Q43262208 | Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers |
| Q33899683 | Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins |
| Q89514186 | Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection |
| Q37484024 | Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors |
| Q60191842 | Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15 |
| Q37993590 | Recent Advances In Developing Synthetic Carbohydrate-Based Vaccines For Cancer Immunotherapies |
| Q33746856 | Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs |
| Q60525921 | Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells |
| Q38207986 | Sarcoma immunotherapy: past approaches and future directions |
| Q36281169 | Synthesis of 4” manipulated Lewis X trisaccharide analogues |
| Q38355359 | Synthesis of Lewis X trisaccharide analogues in which glucose and rhamnose replace N-acetylglucosamine and fucose, respectively |
| Q33689062 | Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine |
| Q48966644 | T/Tn immunotherapy avoiding immune deviation |
| Q47135344 | Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. |
| Q34188015 | The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens |
| Q41432872 | The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy |
| Q34290892 | The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: past, present and future |
| Q37559776 | The engagement of selectins and their ligands in colorectal cancer liver metastases |
| Q34622638 | The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression |
| Q26775411 | The prognostic value of ABO blood group in cancer patients |
| Q37962848 | Toward Automated Oligosaccharide Synthesis |
| Q37146338 | Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct |
| Q33709659 | Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation |
| Q50773568 | Update of the treatment of advanced prostate cancer and management of its complications |
| Q53892129 | Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses |
| Q43093172 | What makes cancer stem cell markers different? |
| Q46767596 | Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins |
| Q42032234 | ‘Biologic’ level structures through chemistry: a total synthesis of a unimolecular pentavalent MUCI glycopeptide construct |
Search more.